AGIOS PHARMACEUTICALS, INC.

AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001439222

Price chart

Open-market purchases and sales by AGIO insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Aug 6, 20264:13 PM ETAug 4, 2026Gheuens SarahChief Medical OfficerSSaleCommon stock−30K$30.48−$914.4K54.65K−35.4%SEC10b5-1
Jul 2, 20264:03 PM ETJul 1, 2026Gheuens SarahChief Medical OfficerSSaleCommon stock−4.01K$37.56−$150.5K84.65K−4.5%SEC10b5-1
Apr 6, 2026Apr 2, 2026Burns James WilliamChief Legal OfficerSSaleCommon stock−3.28K$34.71−$113.85K49.31K−6.2%SEC10b5-1
Apr 6, 2026Apr 2, 2026Gheuens SarahChief Medical OfficerSSaleCommon stock−2.94K$34.71−$102.05K80.28K−3.5%SEC10b5-1
Apr 6, 2026Apr 2, 2026Jones CeciliaChief Financial OfficerSSaleCommon stock−3.14K$34.71−$109.02K55K−5.4%SEC10b5-1

The largest institutional positions in AGIO at the end of Q2 2026.

Institutions holding AGIO in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.6,455,997$239.58M0.00%+701,040+12.2%Added
Farallon Capital Management, L.L.C.5,917,400$219.59M1.29%+233,400+4.1%Added
STATE STREET CORP3,533,633$131.14M0.00%+168,754+5.0%Added
Lynx1 Capital Management LP3,408,937$126.51M14.62%+797,369+30.5%Added
D. E. Shaw & Co., Inc.3,107,005$115.3M0.07%+425,836+15.9%Added